Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study

被引：0

作者：

Rikken, Sem A. O. F. ^{[1
]}

Bor, W. L. ^{[1
]}

Zheng, K. L. ^{[1
]}

Gibson, C. M. ^{[2
]}

Granger, C. B. ^{[3
]}

Coller, B. S. ^{[4
]}

Bentur, O. ^{[4
]}

Lobatto, R. ^{[5
]}

Postma, S. ^{[6
]}

Van 't Hof, A. W. J. ^{[7
]}

Ten Berg, J. M. ^{[1
]}

机构：

[1] St Antonius Hosp, Nieuwegein, Netherlands

[2] Boston Clin Res Inst, Boston, MA USA

[3] Duke Univ, Dept Cardiol, Sch Med, Durham, NC USA

[4] Rockefeller Univ, Allen & Frances Adler Lab Blood & Vasc Biol, New York, NY USA

[5] RP&L Consultancy BV, Wassenaar, Netherlands

[6] Diagram BV, Zwolle, Netherlands

[7] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands

来源：

关键词：

D O I：

10.1093/cvr/cvac157.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1